共 160 条
[1]
Ong J(2005)Predictors of nonalcoholic steatohepatitis and advanced fibrosis in obese patients Obes Surg 15 310-315
[2]
Elariny H(2004)Nonalcoholic steatohepatitis Curr Treat Options Gastroenterol 7 423-430
[3]
Collantes R(2004)Non-alcoholic steatohepatitis in patients cared in metabolic units Diabetes Res Clin Pract 63 143-151
[4]
Younoszai A(2004)Obesity and non-alcoholic fatty liver disease in chronic hepatitis C J Clin Gastroenterol 38 705-709
[5]
Chandhoke V(2000)Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) Hepatology 32 477-481
[6]
Reines HD(2005)Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 1898-1906
[7]
Mulhall BP(2002)The utility of radiological imaging in nonalcoholic fatty liver disease Gastroenterology 123 745-750
[8]
Younossi ZM(2007)Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) Transl Res 149 114-125
[9]
Marchesini G(2007)Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia Aliment Pharmacol Ther 25 207-218
[10]
Bugianesi E(2006)Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice Gut 55 415-424